CN105853911A - Prescription for treating cytomegalovirus infectious heptitis - Google Patents
Prescription for treating cytomegalovirus infectious heptitis Download PDFInfo
- Publication number
- CN105853911A CN105853911A CN201610255404.4A CN201610255404A CN105853911A CN 105853911 A CN105853911 A CN 105853911A CN 201610255404 A CN201610255404 A CN 201610255404A CN 105853911 A CN105853911 A CN 105853911A
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma
- prescription
- treating
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a prescription for treating cytomegalovirus infectious hepatitis. The prescription for treating the cytomegalovirus infectious hepatitis is prepared from the following raw-material components in proportions by weight: 3 parts of aromatic turmeric root-tuber, 2 parts of fructus schisandrae chinensis, 1 part of radix bupleurum Chinese, 1 part of fructus forsythiae, 1 part of cortex moutan, 1 part of herba ardisiae japonicae, 1 part of rhizoma paridis chinensis, 1 part of root of rhizoma polygoni cuspidate, 2 parts of herba lobeliae chinensis, 2 parts of herba hedyotidis diffusae, 1 part of rhizoma atractylodis macrocephalae preparata, 1 part of rhizoma alismatis and 2 parts of radix pseudostellariae. The raw-material components are decocted with water for half an hour, and filtrate is orally taken; a dose is taken every day, and is orally taken twice or thrice; the filtrate is orally taken for 1 month to 3 months.
Description
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to a kind of prescription treating cytomegalovirus infectivity hepatitis.
Background technology
Viral hepatitis serious threat human health, the commonly encountered diseases of Yi Shi China and frequently-occurring disease.Chronic hepatitis can
Progress to hepatic fibrosis, and develop into liver cirrhosis, End-stage liver disease etc..In each Clinical types hepatitis,
Simple infection rate is 61.4%, and superinfection rate is 32.4%, and triple infection rate is 6.5%.Rough estimation,
China is used for the direct medical cost of hepatitis symptomatic treatment every year more than 100,000,000,000 yuans.Except first, second,
The third, outside the hepatitis that hepatitis E virus is caused, at present it has been demonstrated that cytomegalovirus (CMV), simple
Herpesvirus (HHV) etc. all can cause viral hepatitis.
Cytomegalovirus (CMV) is also known as cells inclusions virus, due to the cell enlargement infected, and has huge
Intranuclear inclusion, therefore named.It is a kind of herpesvirus group DNA viruses.Widely distributed, other animals are all
Can be infected, causing with urogenital system, central nervous system and liver disease is main each system sense
Dye, from slight symptomless infection until major defect or death.
Cytomegalovirus Infection is that the congenital or posteriority caused by cytomegalovirus (CMV) infects, multilist
It is now stealthy infection, clinic most commonly interstitial pneumonia, hepatitis, gastroenteritis, retinitis etc..
Summary of the invention
It is an object of the invention to provide a kind of prescription treating cytomegalovirus infectivity hepatitis.
To achieve these goals, the technical solution used in the present invention is:
A kind of prescription treating cytomegalovirus infectivity hepatitis, the weight proportion of its each raw material components is: wide
Radix Curcumae 3, Chinese Magnoliavine 2, Radix Bupleuri 1, Fructus Forsythiae 1, Cortex Moutan 1, PINGDIMU 1, Rhizoma Paridis 1, Rhizoma Polygoni Cuspidati
Root 1, Herba Lobeliae Chinensis 2, Herba Hedyotidis Diffusae 2, Rhizoma Atractylodis Macrocephalae (parched) 1, RHIZOMA ALISMATIS 1, Radix Pseudostellariae 2, decocting half an hour,
Filtrate is administered orally;Potion, divided two to three times and was administered orally every day;Oral one to three month.
The prescription for the treatment of cytomegalovirus infectivity hepatitis provided by the present invention, its therapeutic effect is good, nontoxic
Side effect.Cytomegalovirus belongs to the categories such as the vaginal bleeding during pregnancy of the traditional Chinese medical science, frequent fetal movement, induced abortion, habitual abortion, and it is sick
Because mostly being congenital innate deficiency or losing the day after tomorrow foster, so that positive QI-insufficiency, and the place of defending does not infects evil poison admittedly, its
Property heat, there is infectiousness.So-called " being gathered of heresy, its gas must be empty ", Chinese medicine thinks that the kidney being the origin of congenital constitution,
Main reproduction, is the important internal organs promoting growth in humans to grow, sustain life and produce offspring.If the essence of parents
Deficiency, tire does not become real, then affects nausea, and modern medicine is thought owing to gestation causes immunological function repression to promote
The generation of cytomegalovirus infection and the activation of latent virus, so cause fetal in utero to infect, chorion
And blood capillary skin is impaired, placental barrier destroys, and pathogen enters embryo.The traditional Chinese medical science is thought, the primary disease origin cause of formation is many
Being caused hepatitis by retention of damp-heat in the interior, damp-heat blocking in the body in liver and gall and lose in thin profit, bile leaks, and overflows caused by skin.This
Using soothing the liver blood stasis dispelling, eliminating damp-heat, heat-clearing and toxic substances removing in the side that invention provides, strengthening the body resistance, with the most strongly fragrant in side
Gold, Radix Bupleuri, PINGDIMU, Rhizoma Paridis are with soothing the liver, blood stasis dispelling, polygoni cuspidati,radix, Herba Lobeliae Chinensis, Fructus Forsythiae, pellet
Skin, RHIZOMA ALISMATIS, Herba Hedyotidis Diffusae are with heat clearing away, dampness removing, removing toxic substances, and Radix Pseudostellariae, Rhizoma Atractylodis Macrocephalae (parched), Chinese Magnoliavine are to hold up
Just consolidate.All medicines share the curative effect reaching treating both the principal and the secondary aspects of a disease at the same time.
Detailed description of the invention
Below in conjunction with embodiment, the invention will be further described.
A kind of prescription treating cytomegalovirus infectivity hepatitis, the weight proportion of its each raw material components is: wide
Radix Curcumae 3, Chinese Magnoliavine 2, Radix Bupleuri 1, Fructus Forsythiae 1, Cortex Moutan 1, PINGDIMU 1, Rhizoma Paridis 1, Rhizoma Polygoni Cuspidati
Root 1, Herba Lobeliae Chinensis 2, Herba Hedyotidis Diffusae 2, Rhizoma Atractylodis Macrocephalae (parched) 1, RHIZOMA ALISMATIS 1, Radix Pseudostellariae 2.
Above-mentioned medical material was soaked in water after half an hour, then decocting half an hour, and filtrate is administered orally;Every day, potion, divided
It is administered orally for two to three times;Oral one to three month is a course for the treatment of.
57 example patients are treated by clinic, the maleest 36 examples, female 21 example, the oldest 7 years old, minimum
10 months, after taking medicine three months, glutamate pyruvate transaminase (ACT), glutamic oxaloacetic transaminase, GOT (AST), total bilirubin were just
Often, giant cell is turned out cloudy 54 examples, total cure rate 94.7%.ACT, AST, total bilirubin are normal, giant cell sun
Property person 2 example, total effective rate 98.2%.
Claims (1)
1. treating a prescription for cytomegalovirus infectivity hepatitis, the weight proportion of its each raw material components is:
RADIX CURCUMAE 3, Chinese Magnoliavine 2, Radix Bupleuri 1, Fructus Forsythiae 1, Cortex Moutan 1, PINGDIMU 1, Rhizoma Paridis 1, tiger
Cane root 1, Herba Lobeliae Chinensis 2, Herba Hedyotidis Diffusae 2, Rhizoma Atractylodis Macrocephalae (parched) 1, RHIZOMA ALISMATIS 1, Radix Pseudostellariae 2, decocting half an hour,
Filtrate is administered orally;Potion, divided two to three times and was administered orally every day;Oral one to three month.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610255404.4A CN105853911A (en) | 2016-04-14 | 2016-04-14 | Prescription for treating cytomegalovirus infectious heptitis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610255404.4A CN105853911A (en) | 2016-04-14 | 2016-04-14 | Prescription for treating cytomegalovirus infectious heptitis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105853911A true CN105853911A (en) | 2016-08-17 |
Family
ID=56632878
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610255404.4A Pending CN105853911A (en) | 2016-04-14 | 2016-04-14 | Prescription for treating cytomegalovirus infectious heptitis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105853911A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115554248A (en) * | 2022-08-25 | 2023-01-03 | 平阳润德医院有限公司 | Enteric-coated traditional Chinese medicine preparation for treating infantile cytomegalovirus infectious hepatitis and preparation method thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1460514A (en) * | 2003-07-08 | 2003-12-10 | 中国人民解放军第三○二医院 | Chinese medicine composite for curing chronic hepatitis B, fibrosis of liver and for curing SARS |
-
2016
- 2016-04-14 CN CN201610255404.4A patent/CN105853911A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1460514A (en) * | 2003-07-08 | 2003-12-10 | 中国人民解放军第三○二医院 | Chinese medicine composite for curing chronic hepatitis B, fibrosis of liver and for curing SARS |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115554248A (en) * | 2022-08-25 | 2023-01-03 | 平阳润德医院有限公司 | Enteric-coated traditional Chinese medicine preparation for treating infantile cytomegalovirus infectious hepatitis and preparation method thereof |
CN115554248B (en) * | 2022-08-25 | 2023-09-22 | 平阳润德医院有限公司 | Enteric-coated traditional Chinese medicine preparation for treating infant cytomegalovirus infectious hepatitis and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6455078B1 (en) | Medicinal herbal composition for treating liver diseases and HIV | |
CN110870402A (en) | Prescription for treating pneumonia infected by novel coronavirus and application thereof | |
EP1386614A1 (en) | Herbal pharmaceutical composition for treatment of hiv/aids patients | |
CN1329047C (en) | Chinese medicinal composition for treating acute icterohepatitis | |
CN105853911A (en) | Prescription for treating cytomegalovirus infectious heptitis | |
CN105288513A (en) | Traditional Chinese medicine composition for treating hepatitis B and cirrhosis | |
CN105012485A (en) | Traditional Chinese medicine granule for treating neonatal jaundice | |
CN101461857B (en) | Medicament for treating severe hepatitis | |
CN106177156A (en) | A kind of Chinese medicine composition preventing and treating infectious bovine rhinotrachetis and application thereof | |
CN103536851A (en) | Traditional Chinese medicine composition for treating alcoholic fatty liver | |
CN113476542B (en) | Application of composition in preparation of medicines and kits | |
CN103505500B (en) | A kind of Chinese medicine composition for the treatment of hepatitis B and preparation method thereof | |
CN105940777B (en) | A kind of antiviral Chinese medicine composition | |
CN102225185B (en) | Traditional Chinese medicine composition for treating condyloma acuminatum and preparation method thereof | |
CN103191386B (en) | Medicament for treating chronic hepatitis B | |
CN106492016A (en) | A kind of compound Chinese medicinal preparation of anti-pig blue-ear disease and preparation method thereof | |
CN102370753A (en) | Chinese herbal medicine decoction for treating herpes zoster | |
CN100409865C (en) | Compound medicine for treating hepatitis B | |
Yan et al. | Current state of clinical diagnosis and treatment of infantile cytomegaloviral hepatitis | |
CN104706741A (en) | Traditional Chinese medicine for treating hepatitis | |
CN100335101C (en) | Dysmenorrhea treating medicine | |
CN103585239B (en) | A kind of preparation method of Boraginaceae extract and application thereof | |
CN104042873A (en) | Chinese herbal mixture for treatment of syndrome of internally blocked epidemic toxin of fulminant dysentery | |
CN103585219B (en) | The application of a kind of Altay Heteropappus hispidus (Thunb.) Less.-Aster hispidus Thunb. extract in preparation treatment AIDS-treating medicine | |
CN104069404A (en) | Traditional Chinese medicine composition for treating oxyhepatitis or chronic hepatitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160817 |
|
RJ01 | Rejection of invention patent application after publication |